Nantahala Capital Management, LLC Q1 2022 Filing

Filed May 13, 2022

Portfolio Value

$2.3B

Holdings

115

Report Date

Q1 2022

Filing Type

13F-HR

All Holdings (115 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	—WEJO GROUP LIMITED	214,966	$857K	0.04%
102	UNCYUNICYCIVE THERAPEUTICS INC	640,633	$826K	0.04%
103	—PERELLA WEINBERG PARTNERS	409,128	$822K	0.04%
104	TNGXTANGO THERAPEUTICS INC	98,794	$749K	0.03%
105	AKBAAKEBIA THERAPEUTICS INC	965,800	$693K	0.03%	Call
106	CGTXCOGNITION THERAPEUTICS INC	196,402	$540K	0.02%
107	TACTTRANSACT TECHNOLOGIES INC	71,335	$504K	0.02%
108	—ELOXX PHARMACEUTICALS INC	774,767	$434K	0.02%
109	GLMDGALMED PHARMACEUTICALS LTD	258,957	$412K	0.02%
110	—HTG MOLECULAR DIAGNOSTICS IN	285,963	$397K	0.02%
111	—FINTECH ACQUISITION CORP V	333,331	$317K	0.01%
112	—FINTECH ACQUISITION CORP VI	249,998	$143K	0.01%
113	—B RILEY PRINCIPAL 150 MERGER	120,686	$109K	0.00%
114	—QUALTEK SERVICES INC	96,244	$56K	0.00%
115	OCGNOCUGEN INC	16,571	$55K	0.00%

PreviousPage 2 of 2